- Home
- LNTH vs MTN Comparison
LNTH vs MTN Comparison
Compare LNTH & MTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | MTN |
|---|---|---|
| Founded | 1956 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.9B |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | LNTH | MTN |
|---|---|---|
| Price | $79.49 | $131.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $83.20 | ★ $165.50 |
| AVG Volume (30 Days) | ★ 1.0M | 792.3K |
| Earning Date | 05-25-2026 | 06-08-2026 |
| Dividend Yield | N/A | ★ 6.56% |
| EPS Growth | N/A | ★ 24.05 |
| EPS | ★ 3.41 | 0.65 |
| Revenue | $343,374,000.00 | ★ $2,964,347,000.00 |
| Revenue This Year | N/A | $1.54 |
| Revenue Next Year | $13.47 | $4.12 |
| P/E Ratio | ★ $23.56 | $207.78 |
| Revenue Growth | ★ 3.62 | 2.74 |
| 52 Week Low | $47.27 | $124.36 |
| 52 Week High | $108.86 | $175.51 |
Technical Indicators
Market Signals| Indicator | LNTH | MTN |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 43.36 |
| Support Level | $77.38 | $130.56 |
| Resistance Level | $83.53 | $148.69 |
| Average True Range (ATR) | 3.71 | 5.78 |
| MACD | 0.28 | -0.50 |
| Stochastic Oscillator | 60.42 | 41.79 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About MTN Vail Resorts Inc.
Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.